文献速递其他结缔组织病

局限性皮肤型系统性硬化症评估的结构域与结局指标:一项国际合作范围综述

Domains and outcome measures for the assessment of limited cutaneous systemic sclerosis: an international collaborative scoping review.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

该范围综述检索MEDLINE和Embase,筛选3964条题录后纳入270篇文章,旨在全面识别自1988年局限性皮肤型系统性硬化症(lcSSc)共识定义获认可以来用于评估该病的结构域和工具,为创建CRISTAL应答指数提供依据。共识别27个结构域、459种工具,皮肤受累、肺部受累及健康相关生活质量与一般功能相关工具最常被检索到;lcSSc患者在文献中代表性不足。

要点

  • 共识别27个结构域、459种工具,皮肤、肺和健康相关生活质量工具最常用。
  • 15种最常作为主要终点的工具中,7种为临床医生报告结局,7种为患者报告结局,1种为6分钟步行试验。
  • 纳入研究中lcSSc患者平均比例为56.4%,低于注册研究中60%至80%的患病率,提示代表性不足。

核心结论

  • 该范围综述全面识别了用于评估lcSSc的结构域和结局指标,并提示lcSSc在文献中代表性不足。

研究设计与样本

  • 国际合作范围综述,检索MEDLINE和Embase,由两名评价者筛选3964条题录,最终纳入270篇文章进行数据提取。

主要发现

  • 共识别27个结构域、459种工具,皮肤受累、肺部受累及健康相关生活质量与一般功能相关工具最常被检索到。
  • 15种最常作为疗效或有效性研究主要终点的工具中,7种为临床医生报告结局,7种为患者报告结局,1种为表现结局(6分钟步行试验)。
  • 纳入lcSSc研究(包括同时提及lcSSc和dcSSc的研究)中lcSSc患者平均比例为56.4%,而国家注册研究和国际队列中lcSSc患病率为60%至80%。

局限性

  • 初步评估文献发现极少数研究仅纳入lcSSc受试者,因此也评估了同时包含两种皮肤亚型的文献。
  • 纳入研究中lcSSc患者平均比例为56.4%,低于注册研究中60%至80%的患病率,提示该亚型在文献中代表性不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aim of this study was to comprehensively identify instruments within relevant domains employed to assess lcSSc since the endorsement of its consensus definition in 1988. The overall objective is to inform the creation of a Combined Response Index for Scleroderma Trials Assessing lcSSc (CRISTAL). METHODS: MEDLINE and Embase were searched using terms selected to comprehensively retrieve titles and abstracts mentioning both lcSSc and dcSSc, along with those only mentioning lcSSc, SSc sine scleroderma, limited SSc and/or CREST/CRST. Because our initial assessment of the literature revealed that very few studies included only lcSSc subjects, we also assessed literature that included both cutaneous subsets. A total of 3964 titles and abstracts were screened by two reviewers, and 270 articles were selected for data extraction. RESULTS: We identified 27 domains encompassing 459 instruments. Instruments from 'Skin involvement', 'Pulmonary involvement' and 'Health-related quality of life and general functioning' were the most frequently retrieved. Among the 15 most represented instruments announced as primary end points in efficacy or effectiveness studies, 7 were clinician-reported outcomes (ROs), 7 were patient ROs, and one was a performance outcome (6 min-walk test). The mean proportion of lcSSc patients in studies of lcSSc, including studies that mention both lcSSc and dcSSc, was 56.4%, demonstrating that this subset is underrepresented in the literature, given that the prevalence of lcSSc ranges from 60% to 80% in national registries and international cohorts. CONCLUSION: This scoping literature review provides a comprehensive identification of domains and outcomes used to assess lcSSc. Our results also highlight that lcSSc is underrepresented in the literature.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Lescoat A, Sandler RD, Zimmermann F, et al. Domains and outcome measures for the assessment of limited cutaneous systemic sclerosis: an international collaborative scoping review. Rheumatology (Oxford). 2022. PMID: 35094049. doi:10.1093/rheumatology/keac049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。